Two Stocks That Have Deerfield Management And Anchor Bolt Capital Excited
In a recent filing with the Securities and Exchange Commission (SEC), James E. Flynn (pictured) has revealed his latest play: Akari Therapeutics PLC (ADR) (NASDAQ:AKTX), a clinical-stage biopharmaceutical...